Key result
Minimally invasive mitral valve repair was associated with significantly lower long-term mortality (1.7% vs. 18%) and a lower recurrence of moderate mitral regurgitation compared to conventional surgery.
Why the study?
Does minimally invasive mitral valve repair improve long-term clinical and echocardiographic outcomes compared to conventional mitral valve surgery in patients undergoing elective mitral valve repair?
Observational (n=96)
No
Does minimally invasive mitral valve repair improve long-term clinical and echocardiographic outcomes compared to conventional mitral valve surgery in patients undergoing elective mitral valve repair?
Absolute Event Rate: 1.7% vs 18%
p-value: p=0.004
Minimally invasive mitral valve repair is a safe and feasible alternative to conventional surgery, demonstrating excellent long-term survival and freedom from recurrent mitral regurgitation in selected patients.
May support minimally invasive mitral repair in selected patients; hypothesis-generating and requires randomized confirmation before practice change.
Objectives: To compare the long term outcomes between minimally invasive mitral valve repair (MiMVR) and conventional surgery. Current retrospective comparisons between the techniques frequently report echocardiographical (echo) outcomes early after surgery and rarely report them later. Methods: Patients were selected for MiMVR by the surgical multi-disciplinary meeting from June 2008-March 2013. Patients included had at least two transthoracic post-operative echocardiograms. Echocardiographic parameters including left ventricular size and systolic function, degree of mitral regurgitation (MR) and mean mitral valve gradient were recorded. Clinical outcomes including all-cause mortality, re-operation, recurrence of at least moderate MR and elevated mean mitral valve gradients > 5 mmHg were recorded and compared using Kaplan-Meier survival analysis. Results: 223 patients were screened, 96 (43%) met the criteria and were included. Thirty-seven patients underwent conventional surgery and 59 underwent MiMVR. Mean clinical follow-up was 6.3 years and echo follow up was 3.2 years. There was a significantly higher recurrence of moderate MR in the conventional group (38% (n = 19) versus 17% (n = 10)). The mean LV end-diastolic diameter was 4.8 cm (conventional) versus 5.0 cm (MiMVR). The incidence of elevated PG was 26% (n = 13, conventional) and 23% (n = 14, MiMVR). There was no significant difference in incidence in re-operation (conventional 12% (n = 6), MiMVR 8.3% (n = 5)). Long-term mortality was higher in the conventional group (1.7% vs. 18% p = 0.004) although the logistic Euroscore was significantly higher 6.8% ± 5.4 vs. 3.6% ± 1.6. Conclusions: Minimally invasive mitral valve surgery is safe and feasible in selected patients with good medium and long-term echocardiographic follow-up.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2018) conducted an observational in Severe mitral regurgitation (n=96). Minimally invasive mitral valve repair vs. Conventional mitral valve surgery was evaluated on Long-term all-cause mortality (p=0.004). Minimally invasive mitral valve repair was associated with significantly lower long-term mortality (1.7% vs. 18%) and a lower recurrence of moderate mitral regurgitation compared to conventional surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: